Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gavi alliance

- PMLiVE

UK to use GSK’s Rotarix in rotavirus vaccination programme

Chosen ahead of Merck & Co’s RotaTeq

Novartis building

Canada and Switzerland lift Novartis flu vaccines ban

Independent tests confirm safety following contamination fears

- PMLiVE

Guide to gamification

How to execute digital: Using gaming as part of a pharma marketing campaign

Novartis building

France, Germany and Spain join list of countries banning Novartis vaccines

Flu vaccines Agrippal and Fluad withdrawn after some batches found to be contaminated

EU flag

Europe misses flu vaccine target for at-risk groups

Netherlands only country where coverage is at recommended level, says WHO

- PMLiVE

Data-driven pharma marketing

The most successful organisations of the future will be the ones that are able to ride the ‘data tsunami’ to gain a competitive advantage – and understanding data generated by...

GSK partners with Aeras on TB vaccine

Will begin phase II trials in Kenya, India and South Africa

- PMLiVE

Pakistan to use GSK’s Synflorix in national pneumococcal vaccination programme

Company will supply it at 90 per cent discount through the GAVI Alliance

- PMLiVE

Takeda pays $60m for vaccine company LigoCyte

Gains first-in-class norovirus candidate and new vaccine platform

- PMLiVE

Treating the brain with software

Clinical trials of game-like software designed to re-programme the brain and tackle some of the most intractable symptoms of schizophrenia could usher in a new way to treat a range...

Eurocine Vaccines appoints chief scientific officer and chief business officer

Anna-Karin Maltais and Emma Berglund both receive promotions

EU flag

European vaccines market set to double by 2018

“Huge growth potential” in areas of unmet medical need say Frost & Sullivan

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links